Preventive surgery of inherited colorectal cancer identified through molecular diagnostics

Numerous inherited genetic changes predisposing to cancer have already been identified and the number is increasing. Accurate prediction of individual risk by means of molecular diagnosis implies clinical consequences in the treatment of cancer-predisposing syndromes. Using familial adenomatous poly posis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC) as an ex ample, we present here the underlying genetic changes that contribute to tu mor development. These genetic alterations can be efficiently identified th rough molecular diagnostic techniques. Identification of the familial germl ine mutation permits one to distinguish mutation carriers from non-mutation carriers within affected families and results in individually tailored sur veillance and prevention. Therefore, molecular diagnosis is making a contri bution to the advances in preventive surgical therapy. The indications are discussed.